Dr. Nicolas Chemali is the Senior Vice President for Pricing and Market Access for International at Eli Lilly & Company covering Japan, Europe, China, Middle East, Canada, Latin and South America, Asia, and Africa since January 2017. 

Dr. Chemali is an expert in health economics, health care policies and market access strategies; tailoring corporate access solutions that integrate public private partnerships, and alternative pricing and access strategies to answer markets’ local needs for better healthcare delivery.

Throughout his 25 years of experience in the pharmaceutical industry, of which 23 years at Eli Lilly & Company, Dr. Chemali held different positions in Corporate Affairs, Pricing and Market Access covering Global, Europe, China, and Japan, as well as regional assignments within Europe and Emerging Markets. 

Dr. Chemali is a graduate of the Faculty of Medicine and Human Sciences of St Joseph University. He holds a master’s degree in healthcare management from the Ecole Centrale of Paris (ECP). He is an Infectious Diseases and Oncology expert, having completed his specialties at the University of Paris (Pitié Salpêtrière).

He joined the Global Executive MBA program of Duke University – Fuqua School of Business in the United States and received his MBA degree in 2007. He was also part of multiple executive education programs at Harvard Business School and the University of Chicago, specializing in pricing strategies, negotiation tactics and leading global businesses.